Aptamers inhibiting the enzymatic activity of the MMP-9 protein

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9902961
SERIAL NO

15108681

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to an aptamer that has a G-quadruplex structure and is able to inhibit the enzymatic activity of the MMP-9 protein, as well as to the dermatological and cosmetic uses thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM);L V M H RECHERCHE;LVMH RECHERCHE

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cauchard, Jean Hubert Orleans, FR 5 31
Dausse, Eric Bordeaux, FR 5 17
Kurfurst, Robin Saint Jean de Braye, FR 13 67
Schnebert, Sylvianne Olivet, FR 6 69
Toulme, Jean-Jacques Lormont, FR 5 17

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 27, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 27, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00